TFF Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2019 to Q2 2024.
  • TFF Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 3.67M shares, a 153% increase year-over-year.
  • TFF Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.79M shares, a 49.5% increase from 2022.
  • TFF Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.2M shares, a 95.2% decline from 2021.
  • TFF Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 24.8M shares, a 6105% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 3.67M +2.22M +153% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 2.39M +940K +64.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.79M +593K +49.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 47.4M +22M +86.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.45M -23.9M -94.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.45M -23.9M -94.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 1.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 25.5M +79.9K +0.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 25.4M +4.56K +0.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 25.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 25.4M +25M +6243% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 25.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2020 400K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q1 2020 400K 0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 400K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.